Across TCGA pan-cancer cohorts, RN7SL833P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL833P’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL833P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL833P is over-expressed in tumor.
LUAD are the cancer types where RN7SL833P tumor–normal differential expression is most reproducible.